In the last trading session, 2.2 million shares of the Virpax Pharmaceuticals Inc (NASDAQ:VRPX) were traded, and its beta was 1.25. Most recently the company’s share price was $2.07, and it changed around -$0.43 or -17.12% from the last close, which brings the market valuation of the company to $2.57M. VRPX currently trades at a discount to its 52-week high of $117.25, offering almost -5564.25% off that amount. The share price’s 52-week low was $2.38, which indicates that the current value has fallen by an impressive -14.98% since then. We note from Virpax Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.67 million shares, with the 3-month average coming to 293.13K.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
Instantly VRPX has showed a red trend with a performance of -17.12% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 4.33 on recent trading dayincreased the stock’s daily price by 52.19%. The company’s shares are currently down -78.20% year-to-date, but still down -50.27% over the last five days. On the other hand, Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is -71.21% down in the 30-day period. We can see from the shorts that 38213.0 shares have been sold at a short interest cover period of 0.08 day(s).
The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 31.0% from its current value. Analyst projections state that VRPX is forecast to be at a low of $3 and a high of $3.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 24.10%.
VRPX Dividends
Virpax Pharmaceuticals Inc’s next quarterly earnings report is expected to be released on 2025-Mar-02.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.96% of Virpax Pharmaceuticals Inc shares, and 0.40% of them are in the hands of institutional investors. The stock currently has a share float of 0.41%. Virpax Pharmaceuticals Inc stock is held by 11.0 institutions, with PARALLEL ADVISORS, LLC being the largest institutional investor. By 2024-06-30, it held 0.0001% of the shares, which is about 1.0 shares worth $1.0.
Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 25.31 shares worth $52385.0, making up 0.10% of all outstanding shares. On the other hand, Fidelity Total Market Index Fund held roughly 8.76 shares worth around $18124.0, which represents about 0.03% of the total shares outstanding.
